Downloads: 1 | Views: 193 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Case Studies | Cardiology Science | Morocco | Volume 12 Issue 1, January 2023 | Rating: 5 / 10
Acute Heart Failure in the Cardiology Department of the Mohammed VI University Hospital Center in Marrakech: Presentations, Etiologies, Management and Mortality about 223 Cases
A. Ait Yahya [2] | M. A. Choukri | M. El Jamili [2] | S. El Karimi | M. El Hattaoui
Abstract: Introduction: Acute heart failure (AHF) is a serious condition that requires prompt medical attention. It is characterized by the sudden onset of symptoms such as shortness of breath, chest pain, and edema (swelling in the legs and feet). This study aims to describe the patient characteristics and outcomes of AHF at University Hospital Mohammed VI Marrakech. Objective: The results of this study can help healthcare providers better understand the patient population affected by AHF and identify potential risk factors for poor outcomes. Methods: A study was conducted at University Hospital Mohammed VI Marrakech where data was gathered from 223 patients who were admitted with acute heart failure (AHF) between February 2019 and February 2022. The information collected included socio - demographic characteristics, clinical information, and laboratory results. The research team evaluated the duration of hospital stay and the rate of in - hospital mortality for the patients. Results: The study found that the average age of the patients was 56 years with a standard deviation of 17.1 years, and 55.3% of the patients were male. All patients were experiencing symptoms of AHF, with 69.5% of them falling into NYHA functional class III or IV. The majority of patients (63.5%) had significant left ventricular dysfunction. The most prevalent coexisting medical conditions were hypertension (47.6%), and diabetes mellitus (15.2%). Dilated and Ischemic cardiomyopathy were significant causes of heart failure among the patients. The most commonly used treatments included furosemide (92.2%), beta - blockers (4.9%), angiotensin - converting enzyme inhibitors (61.2%), spironolactone (49.3%), digoxin (18.4%), angiotensin receptor blockers (9.7%). At discharge, most of the patients were on diuretic therapy, including 46.6% on furosemide, 60.20% on spironolactone, and 28.20% on thiazides. Beta - blockers represented 33% of prescriptions, and almost half of the patients were on ACE inhibitors. The median length of stay was nine days, and the in - hospital mortality rate was 14.56%. Conclusion: AHF is a significant public health problem, with high in - hospital and post - discharge mortality rates and prolonged hospital stays. Late and symptomatic presentation is common, and the most common causes are preventable and/or treatable co - morbidities, including hypertension and diabetes mellitus.
Keywords: acute heart failure, in - hospital mortality, length of hospital stay, outcomes
Edition: Volume 12 Issue 1, January 2023,
Pages: 1140 - 1143